NEW YORK (GenomeWeb News) - ADA Technologies said today that it has received a $149,121 grant from the National Cancer Institute to develop a nanotechnology-based imaging and sensing platform for discovering cancer biomarkers.
 
ADA said it is developing a sensing platform for analyzing biomolecules, such as cancer biomarkers, “that is more sensitive than existing technologies,” but did not disclose further details of the technology.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.